18 | SEP-363856IBA
03/2024
-
10/2019 |
14 | Trace amine-associated receptor 1IBA
03/2024
-
01/2020 |
9 | Antipsychotic Agents (Antipsychotics)IBA
03/2024
-
01/2018 |
8 | Serotonin (5 Hydroxytryptamine)IBA
08/2023
-
11/2009 |
7 | 4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA
04/2024
-
11/2015 |
7 | 5-HT1A Serotonin ReceptorIBA
08/2023
-
10/2016 |
6 | Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
02/2008
-
01/2002 |
5 | Calcitonin Gene-Related PeptideIBA
02/2008
-
01/2002 |
4 | Serotonin 5-HT1 Receptor AgonistsIBA
08/2023
-
10/2021 |
3 | Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2023
-
10/2019 |
3 | CarrageenanIBA
07/2007
-
02/2003 |
2 | Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
04/2024
-
08/2013 |
2 | Triglycerides (Triacylglycerol)IBA
01/2024
-
12/2021 |
2 | Lurasidone HydrochlorideFDA Link
10/2023
-
01/2018 |
2 | Dopamine (Intropin)FDA LinkGeneric
08/2023
-
02/2016 |
2 | Amisulpride (Solian)IBA
01/2022
-
01/2021 |
2 | T-Type Calcium Channels (T-Type Calcium Channel)IBA
11/2010
-
06/2009 |
2 | olcegepantIBA
02/2008
-
01/2002 |
2 | piperidineIBA
02/2008
-
11/2007 |
1 | 4- (3- fluoro- 2- methylphenyl)- 4,5- dihydrooxazol- 2- ylamineIBA
01/2024 |
1 | RO5166017IBA
01/2024 |
1 | Olanzapine (Zyprexa)FDA Link
01/2024 |
1 | CorticosteroneIBA
01/2024 |
1 | Glutamic Acid (Glutamate)FDA Link
12/2023 |
1 | Risperidone (Risperdal Consta)FDA LinkGeneric
12/2022 |
1 | ProlactinIBA
12/2021 |
1 | CholesterolIBA
12/2021 |
1 | Capsules (Microcapsules)IBA
10/2021 |
1 | TabletsIBA
10/2021 |
1 | Dopamine Receptors (Dopamine Receptor)IBA
01/2021 |
1 | Antidepressive Agents (Antidepressants)IBA
01/2021 |
1 | Chlorpromazine (Thorazine)FDA Link
10/2019 |
1 | Phencyclidine (Angel Dust)IBA
10/2019 |
1 | 3,4-dihydroxyphenylglycolIBA
02/2016 |
1 | Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2016 |
1 | Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
08/2013 |
1 | Orexin Receptor AntagonistsIBA
01/2010 |
1 | Tryptamines (Triptans)IBA
11/2009 |
1 | Sumatriptan (Imigran)FDA LinkGeneric
11/2009 |
1 | OrexinsIBA
07/2009 |
1 | 2- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA
06/2009 |
1 | triphenylphosphine oxideIBA
01/2009 |
1 | Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2009 |
1 | compound 30IBA
10/2008 |
1 | telcagepantIBA
02/2008 |
1 | NeuropeptidesIBA
02/2008 |
1 | Amyloid beta-PeptidesIBA
11/2006 |
1 | Proteins (Proteins, Gene)FDA Link
11/2006 |
1 | Peptides (Polypeptides)IBA
11/2006 |
1 | Amyloid (Amyloid Fibrils)IBA
11/2006 |
1 | BenzodiazepinesIBA
10/2006 |
1 | PiperidinesIBA
10/2006 |